Amedisys Inc
AMEDDelisted Aug 14, 2025- Industry
- Services-Home Health Care Services
- SEC CIK
- 0000896262
Amedisys Inc was delisted on Aug 14, 2025; its insiders filed their last Form 4 on Aug 14, 2025; 321 institutions reported holding it in 13F filings for Q2 2025, worth $3.20B in total; no superinvestor held it.
Key figures
- Insider buys
- 0
- Open market, last 90 days
- Insider sells
- 0
- Open market, last 90 days
- 13F holders
- 321
- Q2 2025, +19 vs. previous quarter
- 13F value
- $3.20B
- Reported value at the end of Q2 2025
- Superinvestors holding
- 0
- At the end of Q2 2025
Superinvestors holding AMED, Q2 2025
No superinvestor reported holding AMED at the end of Q2 2025.
Latest insider trades
Open-market purchases and sales by Amedisys Inc insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| May 9, 2025 (view filing) | May 8 | 1 day | Guidroz AllysonChief Accounting Officer | SSale | −374 | $96.00 | −$35.9K | −4.4%8.11K after | |
| Mar 6, 2025 (view filing) | Mar 4 | 2 days | Guidroz AllysonChief Accounting Officer | SSale | −2.04K | $92.03 | −$187.8K | −18.9%8.76K after | |
| Mar 8, 2023 (view filing) | Mar 3 | 5 daysLate | North Michael PaulChief Information Officer | SSale | −5.91K | $86.43 | −$510.6K | −58.7%4.16K after | |
| Jun 27, 2022 (view filing) | Jun 23 | 4 days | Bohnert Denise M.Chief Compliance Officer | SSale | −557 | $115.00 | −$64.1K | −4.5%11.8K after | |
| Apr 4, 2022 (view filing) | Mar 29 | 6 daysLate | Kemmerly David LSee Remarks | SSale | −2.50K | $177.31 | −$443.3K | −13.3%16.3K after | 3 lots |
| Dec 2, 2021 (view filing) | Nov 30 | 2 days | Lechleiter Richard ADirector | PPurchase | +1.00K | $141.25 | +$141.3K | +12.0%9.37K after | |
| Sep 3, 2021 (view filing) | Sep 1 | 2 days | Perkins Bruce DDirector | SSale | −11.5K | $183.00 | −$2.11M | −39.2%17.9K after | |
| Aug 4, 2021 (view filing) | Aug 2 | 2 days | Gerard ChristopherPresident & COO | SSale | −1.25K | $261.24 | −$326.5K | −3.2%37.9K after | 4 lots |
| Jul 6, 2021 (view filing) | Jul 1 | 5 days | Gerard ChristopherPresident & COO | SSale | −1.25K | $250.90 | −$313.6K | −3.1%39.1K after | 2 lots |
Top 10 13F holders, Q2 2025
The largest institutional positions in Amedisys Inc at the end of Q2 2025; share changes are against Q1 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| BlackRock, Inc. | 3,345,633 | $329.2M | 0.01% | +78,947+2.4% | Added |
| Vanguard Group Inc | 3,041,392 | $299.2M | 0.00% | −156,119−4.9% | Reduced |
| Pentwater Capital Management LP | 1,715,084 | $168.7M | 2.15% | +370,084+27.5% | Added |
| FIL Ltd | 1,312,785 | $129.2M | 0.11% | +433,785+49.3% | Added |
| Alpine Associates Management Inc. | 1,096,920 | $107.9M | 5.78% | +104,800+10.6% | Added |
| State Street Corp | 1,067,613 | $105.0M | 0.00% | +60,030+6.0% | Added |
| Norges Bank | 902,135 | $88.8M | 0.01% | +12,742+1.4% | Added |
| UBS Group AG | 878,850 | $86.5M | 0.02% | +244,349+38.5% | Added |
| TIG Advisors, LLC | 856,753 | $84.3M | 4.60% | +20,336+2.4% | Added |
| Qube Research & Technologies Ltd | 790,548 | $77.8M | 0.11% | +169,444+27.3% | Added |